As a group of chronic and idiopathic gastrointestinal (GI) disorders, inflammatory bowel
disease (IBD) is characterized by recurrent intestinal mucosal inflammation. Oral …

Dietary fiber intake in humans is nowadays substantially decreased as compared to the
communities of ancestral populations. Accompanying that, the incidences of inflammatory …

Hydrogels are a class of biocompatible materials with versatile functions that have been
increasing explored for the localized treatment of ulcerative colitis (UC), but various …

Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical
activity: The “BE-FIT-IBD” study - PMC Back to Top Skip to main content NIH NLM Logo Access …

Background Asia's inflammatory bowel disease (IBD) burden has rapidly increased recently,
but the epidemiological trends in Asia remain unclear. We report IBD's incidence …

Tumor necrosis factor-α (TNF-α) antagonists, the first biologics approved for treating patients
with inflammatory bowel disease (IBD), are effective for the induction and maintenance of …

Inflammatory bowel disease (IBD), consisting of Crohn's disease and ulcerative colitis, is
recognized across the world, though Canada has among the highest burdens of IBD in the …

Aims Inflammatory bowel disease (IBD) is associated with an increased risk of
atherosclerotic cardiovascular disease (ASCVD). We compared cardiovascular disease …

Inflammatory bowel disease (IBD) is an emerging global disease characterised by chronic
inflammation of the gastrointestinal tract. However, IBD is also manifested by several …

Inflammatory bowel diseases (IBDs), encompassing ulcerative colitis (UC) and Crohn's
disease (CD), are chronic gastrointestinal disorders often diagnosed in youth, presenting …